RAPP · Rapport Therapeutics, Inc. · Executive Compensation

$43.62 +0.16 (+0.37%) At close · Sep 11

Russell 2000 member Rebalance outlook locked

Market Cap

$2.09B

47.98M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Abraham N. Ceesay	M.B.A. Chief Executive Officer	$652,927	—	—	$5,156,416	$431,059	$24,772	$6,265,174
Jeffrey Sevigny	Chief Medical Officer	$561,087	—	—	$2,101,230	$283,780	$77,845	$3,023,942
Troy Ignelzi	Chief Financial Officer	$519,846	—	—	$1,710,773	$249,600	$25,920	$2,506,139

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Abraham N. Ceesay	M.B.A. Chief Executive Officer	$576,538	—	—	$8,947,874	$293,590	$21,155	$9,839,157
Troy Ignelzi	Chief Financial Officer	$468,462	—	—	$1,788,835	$170,000	$37,074	$2,464,371
Bradley Galer	Former Chief Medical Officer	$466,885	$75,000	—	$1,707,981	$163,200	$18,408	$2,431,474

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Abraham N. Ceesay	M.B.A. Chief Executive Officer	$400,096	$250,000	—	$1,513,805	$231,167	$20,772	$2,415,840
Troy Ignelzi	Chief Financial Officer	$69,462	—	—	$2,018,084	$35,770	$7,141	$2,130,457

Key facts CIK 2012593 CUSIP 75383L102 13F (30d) 58 filings 58 filers Visit website Investor relations